Track Acasti Pharma Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Acasti Pharma Inc. ACST · Stock Open Acasti Pharma Inc. in new tab

3.37 USD
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Acasti Pharma Inc. (ACST)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Acasti Pharma Inc. Logo Acasti Pharma Inc. Analysis (ACST)

Canada Health Care Official Website Stock

Is Acasti Pharma Inc. a good investment? Acasti Pharma Inc. (ACST) is currently trading at 3.37 USD.

Investor FAQ

Does Acasti Pharma Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Acasti Pharma Inc.?

Acasti Pharma Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Exchange Ticker
NCM (Australia) ACST
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Oct. 15, 2015 1:10
Aug. 31, 2021 0.12
July 10, 2023 0.17
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion